Skip to content

Pfizer PFE Net Change in Cash

Net Change in Cash at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$635M-220%
Eli Lilly logo
Eli LillyLLY
-$1.99B-1,035%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.98B-86.2%
Merck & Co. logo
Merck & Co.MRK
-$9.29B-103%
Amgen logo
AmgenAMGN
$2.91B+192%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$198.88M-999%

Other financials

Income statement

See full
Revenue$14.5B+5.4%
Gross profit$10.9B+0.3%
Net income$2.7B-9.4%
EPS (diluted)$0.47-9.6%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+4.9%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$138.44B+0.2%
Enterprise value$201.11B+1.4%
P/E11.4×
P/S2.2×0.0×

Profitability

See full
Gross margin73.5%+1.2pp
Net margin15.7%
FCF margin18%+8.8pp

Returns & leverage

See full
Return on equity10.6%
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pfizer's net change in cash?
Pfizer (PFE) reported net change in cash of $563M in Q1 2026.
How has Pfizer's net change in cash changed year-over-year?
Pfizer's net change in cash increased by 50.1% year-over-year, from $375M to $563M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.